Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | Structural Heart Occluders

Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...

Home September 13, 2017
Home
News | Peripheral Artery Disease (PAD)

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...

Home September 13, 2017
Home
News | Drug-Eluting Balloons

September 13, 2017 — Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from ...

Home September 13, 2017
Home
News | Peripheral Artery Disease (PAD)

September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...

Home September 13, 2017
Home
Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.
Feature | Cath Lab

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...

Home September 12, 2017
Home
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | TCT
November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has selected ...
Home November 09, 2017
Home
News | Venous Therapies

September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...

Home September 11, 2017
Home
News | Cath Lab

September 11, 2017 — Researchers have led a retrospective single-center study examining simple hemodynamic parameters ...

Home September 11, 2017
Home
Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable | Dave Fornell

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...

Home September 08, 2017
Home
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.
Feature | Left Atrial Appendage (LAA) Occluders

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to ...

Home September 07, 2017
Home
Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.
Feature | ESC

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late ...

Home September 07, 2017
Home
News | Embolic Protection Devices

September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System ...

Home September 07, 2017
Home
Technology | Cardiovascular Ultrasound

September 6, 2017 — The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application ...

Home September 06, 2017
Home
News | Heart Failure

September 5, 2017 — Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli ...

Home September 05, 2017
Home
News | Congenital Heart

September 5, 2017 — Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and ...

Home September 05, 2017
Home
Subscribe Now